Maria Ormhøj

3PUBLICATIONS
31CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 24, 2025
De novo-designed pMHC binders facilitate T cell-mediated cytotoxicity toward cancer cells.

Kristoffer Haurum Johansen, Darian Stephan Wolff, Beatrice Scapolo

|Feb 24, 2022
Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials.

Maria Ormhøj, Hinrich Abken, Sine R Hadrup

|Aug 10, 2018
Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.

Irene Scarfò, Maria Ormhøj, Matthew J Frigault

Pageof 1